Kiniksa Pharmaceuticals International, plc
KNSA
$40.59
$0.521.30%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 245.24% | 556.29% | 148.23% | -135.22% | 8.39% |
| Total Depreciation and Amortization | -3.76% | -16.74% | -25.97% | -25.93% | -33.83% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 256.42% | -37.67% | -6.37% | 138.43% | -76.83% |
| Change in Net Operating Assets | -118.15% | 83.19% | -81.36% | 618.48% | -49.12% |
| Cash from Operations | 1,606.13% | 443.54% | 459.92% | 333.99% | -113.16% |
| Capital Expenditure | -- | -- | -17.86% | -244.64% | 100.00% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -878.01% | 92.06% | -300.88% | 541.34% | 48.23% |
| Cash from Investing | -888.58% | 91.70% | -301.93% | 538.38% | 48.29% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 72.88% | 1,022.91% | -20.38% | 184.22% | 467.35% |
| Repurchase of Common Stock | -60.51% | -55.90% | -8.14% | -120.61% | -145.43% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 77.89% | 6,110.11% | -23.39% | 208.20% | 1,111.78% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -806.54% | 183.49% | -179.85% | 973.05% | -136.02% |